Bioventus Inc.
Bioventus Inc. (Nasdaq: BVS) is a global medical device company focused on pain relief and musculoskeletal care, serving patients through physicians, hospitals, ambulatory surgery centers and clinics. Its portfolio spans Pain Treatments, Surgical Solutions and Restorative Therapies, and its reportable segments are… From the company’s description.
Over the twelve months to Sep 26, 2026, Bioventus Inc. reported revenue of $585.64M, up 3.9% from a year earlier, and net income of $64.33M. Its operating margin was 9.7%, and operations generated $87.43M in cash. In fiscal 2025, it reported revenue of $568.09M, down 0.9% from fiscal 2024, and net income of $27.27M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Bioventus Inc. does
In the company’s own words
Bioventus Inc. (Nasdaq: BVS) is a global medical device company focused on pain relief and musculoskeletal care, serving patients through physicians, hospitals, ambulatory surgery centers and clinics. Its portfolio spans Pain Treatments, Surgical Solutions and Restorative Therapies, and its reportable segments are U.S. and International, which contributed 88% and 12% of fiscal 2025 net sales, respectively. Products include hyaluronic acid injections for knee osteoarthritis, peripheral nerve stimulation systems for chronic pain, platelet-rich plasma processing equipment, ultrasonic surgical systems, bone graft substitutes and EXOGEN ultrasound systems for fracture healing. Major brands include Durolane, StimRouter, BoneScalpel, neXus, OSTEOAMP, SIGNAFUSE and EXOGEN. Bioventus sells through direct and indirect sales teams in the United States and a combination of direct sales, indirect sales and distributors internationally. It manufactures and assembles most of its medical devices at its production facility in Tennessee. Its website is www.bioventus.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- DURHAM, NC
- Fiscal year end
- December
- CIK
- 1665988
- SIC
- 3841
Financial performance, year by year
Fiscal 2021–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Bioventus Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Bioventus Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Bioventus Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Bioventus Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Bioventus Inc.'s last four quarterly filings that the numbers alone won't show?”